Literature DB >> 2116203

Renal vascular responsiveness to arachidonic acid in experimental diabetes.

J Quilley1, J C McGiff.   

Abstract

1. Isolated perfused kidneys from diabetic rats (duration 4-6 and 20-24 weeks) were more sensitive to the vasoconstrictor effects of arachidonic acid than kidneys from age-matched control rats. Sensitivity diminished with age in both control and diabetic groups. 2. The enhanced vasoconstrictor effect of arachidonic acid in diabetic rat kidneys was associated with increased conversion to prostaglandins. 3. The renal vasoconstrictor response to arachidonic acid in both groups was reduced by thromboxane A2/prostaglandin H2 receptor antagonism but not by inhibition of thromboxane synthase. 4. Diabetic rat kidneys were also more sensitive to the vasoconstrictor effects of the endoperoxide analogue, U46619, while vasoconstrictor responses to phenylephrine were not markedly different from those of control rat kidneys. 5. In conclusion, prostaglandin endoperoxides appear to mediate arachidonic acid-induced vasoconstriction in diabetic and control rat kidneys. The enhanced renal vasoconstrictor response to arachidonic acid in diabetic rats results from increased sensitivity to endoperoxides and increased formation of endoperoxides from arachidonic acid.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2116203      PMCID: PMC1917432          DOI: 10.1111/j.1476-5381.1990.tb15805.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  13 in total

1.  Increased biosynthesis of thromboxane A2 by diabetic platelets.

Authors:  V A Ziboh; H Maruta; J Lord; W D Cagle; W Lucky
Journal:  Eur J Clin Invest       Date:  1979-06       Impact factor: 4.686

2.  Decreased vascular prostacyclin in experimental diabetes.

Authors:  H E Harrison; A H Reece; M Johnson
Journal:  Life Sci       Date:  1978-07-24       Impact factor: 5.037

3.  Vascular prostacyclin may be reduced in diabetes in man.

Authors:  M Johnson; H E Harrison; A T Raftery; J B Elder
Journal:  Lancet       Date:  1979-02-10       Impact factor: 79.321

4.  Altered synthesis of prostaglandins in platelet and aorta from spontaneously diabetic Wistar rats.

Authors:  M T Subbiah; D Dietemeyer
Journal:  Biochem Med       Date:  1980-04

5.  Renal vascular responses and eicosanoid release in diabetic rats.

Authors:  D Sarubbi; J C McGiff; J Quilley
Journal:  Am J Physiol       Date:  1989-11

6.  Increased platelet thromboxane synthesis in diabetes mellitus.

Authors:  P V Halushka; R C Rogers; C B Loadholt; J A Colwell
Journal:  J Lab Clin Med       Date:  1981-01

7.  Increased prostaglandin production by glomeruli isolated from rats with streptozotocin-induced diabetes mellitus.

Authors:  M Schambelan; S Blake; J Sraer; M Bens; M P Nivez; F Wahbe
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

8.  Arachidonic acid metabolism and urinary excretion of prostaglandins and thromboxane in rats with experimental diabetes mellitus.

Authors:  J Quilley; J C McGiff
Journal:  J Pharmacol Exp Ther       Date:  1985-07       Impact factor: 4.030

9.  Vascular responsiveness and eicosanoid production in diabetic rats.

Authors:  D M Roth; D K Reibel; A M Lefer
Journal:  Diabetologia       Date:  1983-05       Impact factor: 10.122

10.  Impact of insulin or tolbutamide treatment on 14C-arachidonic acid conversion to prostacyclin and/or thromboxane in lungs, aortas, and platelets of streptozotocin-induced diabetic rats.

Authors:  M A Valentovic; W C Lubawy
Journal:  Diabetes       Date:  1983-09       Impact factor: 9.461

View more
  2 in total

1.  Improved functional vasodilation in obese Zucker rats following exercise training.

Authors:  Mohamad Sebai; Silu Lu; Lusha Xiang; Robert L Hester
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-06-17       Impact factor: 4.733

2.  Attenuated PGI2 synthesis in obese Zucker rats.

Authors:  Benjamin L Hodnett; Jennifer A Dearman; Cory B Carter; Robert L Hester
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-12-31       Impact factor: 3.619

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.